Consumer Justice Foundation Resources - PRWeb Press Release Group

FDA Urges Doctors to Weigh Risks when Prescribing Depakote to Women According to CJF

Thu, 28 Jul 2011 14:00:00 GMT

New information about Depakote pregnancy risks has led the FDA to urge healthcare professionals to carefully weigh all benefits and risks of Depakote treatment before prescribing the drug to women of childbearing age. Depakote is one of the most commonly prescribed anticonvulsant medications, used in the treatment of epilepsy, seizures, migraine headaches and bipolar disorder. For more information about potential Depakote birth defects or to contact a Depakote attorney, visit http://www.DepakoteBirthInjury.com, a free online resource provided by the Consumer Justice Foundation and intended to help American consumers injured by pharmaceutical drugs.

(PRWeb July 28, 2011)

Read the full story at http://www.prweb.com/releases/2011/7/prweb8676240.htm

FDA Asks Healthcare Professionals to Weigh the Benefits and Risks of Topamax, Reports The CJF

Wed, 20 Jul 2011 14:00:00 GMT

The FDA recently released a safety announcement urging healthcare professionals to consider all benefits and risks involved in Topamax treatment before prescribing the antiepileptic drug to women of childbearing age. According to the FDA, Topamax use during pregnancy may be linked to an increased risk of birth defects among exposed infants, particularly cleft lip and cleft palate. For more information about Topamax FDA warnings and the pregnancy risks of the antiepileptic Topamax, visit http://www.topamaxbirthinjury.com, a free online resource provided by the Consumer Justice Foundation (CJF) to help connect injured consumers with professionals who can help.

(PRWeb July 20, 2011)

Read the full story at http://www.prweb.com/releases/2011/7/prweb8653771.htm

CJF Warns Mothers on Topamax Increase Risk of Children with Oral Clefts

Tue, 12 Jul 2011 14:00:00 GMT

New information has been released by the FDA about potential Topamax birth defects indicates that mothers taking Topamax during pregnancy may have an increased risk of giving birth to children with oral cleft birth defects. Topamax is one of the most frequently prescribed antiepileptic medications for the treatment of epilepsy and migraine headaches, although the drug may no longer be considered safe for women of childbearing age. For more information about Topamax pregnancy risks or to contact a Topamax attorney, visit http://www.topamaxbirthinjury.com, a free online resource provided by the Consumer Justice Foundation for American consumers who have been affected by the antiepileptic Topamax.

(PRWeb July 12, 2011)

Read the full story at http://www.prweb.com/releases/2011/7/prweb8633959.htm

CJF Reports on Alternatives to Controversial Epilepsy Treatments (Topamax and Depakote) During Pregnancy

Thu, 07 Jul 2011 14:00:00 GMT

Epilepsy treatments like Topamax and Depakote have recently come under heavy scrutiny for allegedly leading to a variety of birth defects, ranging from cleft lip and palate to life-altering neural tube defects like spina bifida. The FDA has repeatedly urged physicians to warn women of childbearing age about the birth defect risks associated with such epilepsy treatments during pregnancy. The Consumer Justice Foundation provides further information about the pregnancy risks for women taking these antiepileptic medications, as well as the legal rights of women whose children have been harmed by these drugs during pregnancy at http://www.topamaxbirthinjury.com.

(PRWeb July 07, 2011)

Read the full story at http://www.prweb.com/releases/2011/7/prweb8625586.htm

C.J.F. Urges Women Taking Topamax During Childbearing Years to Become Fully Aware of Newly Found Birth Defect Risks

Thu, 30 Jun 2011 17:15:00 GMT

Serious concerns have been raised about the pregnancy risks associated with Topamax treatment in women of childbearing age. Topamax is one of the most commonly prescribed medications for the treatment of epilepsy and migraine headaches in the U.S., but recent studies have suggested a potential link between Topamax use in pregnancy and serious birth defects. The Consumer Justice Foundation is a free online guide providing resources like http://www.topamaxbirthinjury.com for consumers seeking legal help or information about pharmaceutical birth defect risks.

(PRWeb June 30, 2011)

Read the full story at http://www.prweb.com/releases/2011/6/prweb8613879.htm

New Study Indicates Epilepsy Medication During Pregnancy is More Dangerous Than Going Untreated According to the C.J.F.

Fri, 24 Jun 2011 17:00:00 GMT

A recent study performed by Norwegian researchers and published in the latest issue of BJOG: An International Journal of Obstetrics and Gynaecology indicates that women who use epilepsy drugs during pregnancy may experience more problems while their child is in the womb than those women who do not use these medications. The Consumer Justice Foundation continues to make the effort to alert the public to this potentially important health-related information with free online resources that include http://www.topamaxbirthinjury.com so that expecting mothers and others can obtain an understanding of some of the risks they may be encountering.

(PRWeb June 24, 2011)

Read the full story at http://www.prweb.com/releases/2011/6/prweb8599211.htm

Pharmaceutical Use During Pregnancy Very Common Despite Recent Birth Defect Warnings

Thu, 16 Jun 2011 14:30:00 GMT

A recent study performed by the American Journal of Obstetrics and Gynecology has shown that the number of women taking pharmaceuticals during pregnancy in the United States has risen sharply in the past three decades despite FDA warnings concerning antiepileptic and antidepressant drugs possibly leading to the development of birth defects when taken in pregnancy. The Consumer Justice Foundation works to bring this kind of information to the American public by providing such resources as http://www.topamaxbirthinjury.com in order to educate mothers on the dangers of such drugs during pregnancy.

(PRWeb June 16, 2011)

Read the full story at http://www.prweb.com/releases/2011/6/prweb8576423.htm

Dosage Factors and Safer Alternatives to More Dangerous Antiepileptic Drugs During Pregnancy

Fri, 10 Jun 2011 14:15:00 GMT

A new study published by has indicated that infants exposed to antiepileptic drugs, such as Depakote, during pregnancy may have an even higher risk of developing serious birth defects. However, taking lower doses of Depakote may carry similar risks as higher doses of "safer" antiepileptics. Antiepileptic drugs are commonly prescribed to women suffering from epilepsy and seizure-related disorders, as well as bipolar disorder. The Consumer Justice Foundation has provided more information about antiepileptic drugs such as Depakote, potential antiepileptic birth defects, and seeking legal recourse for these birth defects, at the birth injury resource located at http://www.depakotebirthinjury.com.

(PRWeb June 10, 2011)

Read the full story at http://www.prweb.com/releases/2011/6/prweb8560812.htm

Women Taking Topiramate (Topamax) for Migraine Headaches May be Less Aware of Side Effects

Thu, 09 Jun 2011 14:30:00 GMT

Topiramate is a medication that’s been used for the treatment of the seizures associated with epilepsy, and in recent years it has also been used to treat the symptoms of migraine headaches. The Consumer Justice Foundation hereby announces that it has provided new information regarding the potential effects of Topiramate on unborn children of mothers who have used Topiramate for migraine headaches and who were unaware of the potential Topiramate side effects. This information can be found at http://www.topamaxbirthinjury.com.

(PRWeb June 09, 2011)

Read the full story at http://www.prweb.com/releases/2011/6/prweb8554115.htm

Women Taking Topamax for Migraines Should Know of Increased Pregnancy Risks

Thu, 12 May 2011 13:30:00 GMT

Topamax, a medication that’s prescribed to patients who need help minimizing the symptoms of migraine headaches, has recently come under FDA scrutiny with regards to using Topamax for migraines while pregnant. The Consumer Justice Foundation, a free public resource available for those who need help dealing with insurance companies and large corporations, hereby announces the change in classification by the FDA regarding the use of Topamax in pregnancy. The Consumer Justice Foundation has also provided information regarding this issue at http://www.topamaxbirthinjury.com.

(PRWeb May 12, 2011)

Read the full story at http://www.prweb.com/releases/topamax/side-effects/prweb8415547.htm